Cargando…
Network-based in silico drug efficacy screening
The increasing cost of drug development together with a significant drop in the number of new drug approvals raises the need for innovative approaches for target identification and efficacy prediction. Here, we take advantage of our increasing understanding of the network-based origins of diseases t...
Autores principales: | Guney, Emre, Menche, Jörg, Vidal, Marc, Barábasi, Albert-László |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740350/ https://www.ncbi.nlm.nih.gov/pubmed/26831545 http://dx.doi.org/10.1038/ncomms10331 |
Ejemplares similares
-
Tissue Specificity of Human Disease Module
por: Kitsak, Maksim, et al.
Publicado: (2016) -
Integrating personalized gene expression profiles into predictive disease-associated gene pools
por: Menche, Jörg, et al.
Publicado: (2017) -
A DIseAse MOdule Detection (DIAMOnD) Algorithm Derived from a Systematic Analysis of Connectivity Patterns of Disease Proteins in the Human Interactome
por: Ghiassian, Susan Dina, et al.
Publicado: (2015) -
Network-based approach to prediction and population-based validation of in silico drug repurposing
por: Cheng, Feixiong, et al.
Publicado: (2018) -
A systems biology approach to cGMP suggests a prominent role for sGC in stroke: Validation by mechanism-based activation of apo-sGC in non-steal dosing coveys neuroprotection and increased survival
por: Casas, Ana I, et al.
Publicado: (2015)